World's Best Scientists 2026 revealed!
International Journal of Clinical Oncology
H-index 27

International Journal of Clinical Oncology

1341-9625

Published by: Springer

https://www.springer.com/journal/10147

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Medicine 940 128 254 24

Additional Metrics

Number of Best Scientists*: 211
Documents by Best Scientists*: 377
Top 100 Ranked Scientists*: 3
SCIMAGO H-index: 78
SCIMAGO SJR: 0.936
Impact Factor: 2.8

Overview

Top Research Topics at International Journal of Clinical Oncology?

The journal tackles a plethora of topics, such as Surgical oncology, Internal medicine, Oncology, Chemotherapy and Cancer. The journal is concerned with the study of Surgical oncology and Surgery in general. The Internal medicine study tackled is a key component of adjacent topics in the area of Gastroenterology.

The study on Gastroenterology presented in it intersects with subjects under the field of Hazard ratio. It focused on Hazard ratio research but expanded to cover Proportional hazards model. Issues in Oncology were discussed, taking into consideration concepts from other disciplines like Clinical trial, Survival rate, Regimen, Carcinoma and Breast cancer.

It primarily discusses Chemotherapy topics, particularly Cisplatin, Carboplatin, Combination chemotherapy, Docetaxel and Neutropenia. Oxaliplatin is a major topic of Colorectal cancer research. The in-depth study on Pathology also explores topics in the intersecting field of Metastasis.

  • Surgical oncology (55.16%)
  • Internal medicine (53.08%)
  • Oncology (38.59%)

What are the most cited papers published in the journal?

  • Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer (1289 citations)
  • Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014 for treatment of colorectal cancer (418 citations)
  • Clinical practice guidelines for gastrointestinal stromal tumor (GIST) in Japan: English version (226 citations)

Research areas of the most cited articles at International Journal of Clinical Oncology:

The journal papers cover a variety of subjects, including Surgical oncology, Internal medicine, Oncology, Cancer and Surgery. In addition to Surgical oncology research, the journal articles aim to explore topics under Cancer research, Carcinoma, Pathology and Radiation therapy, Radiology. Internal medicine study tackled in the most cited articles is connected to the field of Gastroenterology.

What topics the last edition of the journal is best known for?

  • Cancer
  • Internal medicine
  • Surgery

The previous edition focused in particular on these issues:

The main points discussed in the journal deals with Internal medicine, Surgical oncology, Oncology, Gastroenterology and Cancer. The presentations focused mostly on Surgical oncology in an attempt to further explore topics in Surgery. The research on Oncology tackled can also make contributions to studies in the areas of Nivolumab and Clinical trial.

International Journal of Clinical Oncology holds forums on Gastroenterology that merges themes from other disciplines such as Phases of clinical research, Febrile neutropenia, Biomarker (medicine), Lung cancer and Risk factor. Research on Cancer addressed in the journal frequently intersections with the field of Cancer research. The Chemotherapy works featured in it incorporate elements from Regimen and Radiation therapy.

The most cited articles from the last journal are:

  • Photodynamic diagnosis and therapy for urothelial carcinoma and prostate cancer: new imaging technology and therapy (12 citations)
  • Optimizing antiemetic treatment for chemotherapy-induced nausea and vomiting in Japan: Update summary of the 2015 Japan Society of Clinical Oncology Clinical Practice Guidelines for Antiemesis. (8 citations)
  • Prognostic value of pre-treatment risk stratification and post-treatment neutrophil/lymphocyte ratio change for pembrolizumab in patients with advanced urothelial carcinoma. (7 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in International Journal of Clinical Oncology (based on the number of publications) are:

  • Hideo Baba (42 papers) published 5 papers at the last edition, 2 more than at the previous edition,
  • Masahiro Hiraoka (33 papers) absent at the last edition,
  • Osamu Ogawa (33 papers) published 1 paper at the last edition, 5 less than at the previous edition,
  • Nobuo Yaegashi (32 papers) published 5 papers at the last edition,
  • Yoshihiko Maehara (30 papers) published 1 paper at the last edition the same number as at the previous edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in International Journal of Clinical Oncology (based on the number of publications) are:

  • Kyoto University (191 papers) published 21 papers at the last edition, 5 more than at the previous edition,
  • Tohoku University (130 papers) published 22 papers at the last edition, 14 more than at the previous edition,
  • Osaka University (120 papers) published 15 papers at the last edition, 6 more than at the previous edition,
  • Kyushu University (107 papers) published 25 papers at the last edition, 17 more than at the previous edition,
  • Keio University (106 papers) published 21 papers at the last edition, 13 more than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 9.23% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 40.65% were posted by at least one author from the top 10 institutions publishing in the journal. Another 13.41% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 14.23% of all publications and 31.71% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Career Paths for Clinical Oncology Researchers

The career trajectory for researchers in the field of Clinical Oncology is as diverse as the field itself. Researchers can choose different avenues depending on their preferences and career aspirations. Many start their careers in academia, conducting research and teaching students at universities. Others work in pharmaceutical companies, developing new drugs and treatments. Some researchers work in hospitals, providing patient care while also conducting research. Graduates have a wide range of job sectors to choose from. Many opt for healthcare organizations, pharmaceutical companies, universities, research institutes, and government agencies. Some prefer non-profit organizations emphasizing cancer prevention and care. Job titles can include Clinical Research Coordinator, Oncology Research Nurse, and Clinical Trials Project Manager. Building a successful career as a clinical oncology researcher requires a strong foundation in biological sciences and other medical research disciplines. Those who wish to embark on this profession should consider obtaining a degree in a medical discipline. Those interested in specializing in nursing for example, can opt for the program in one of the best nursing schools in Arkansas before making their move to more specialized fields. Hard skills such as proficiency in scientific writing, knowledge of statistical analysis, capacities to conduct clinical trials and other forms of research, and understanding of scientific guidelines and protocols are invaluable in this field. Above all, the field requires continuous learning and update in knowledge due to the rapidly evolving nature of cancer research. With the right education, skills, continuous learning, and passion, one can build a very fulfilling career in the clinical oncology research field.

Top Publications

  • Current issues and perspectives in PD-1 blockade cancer immunotherapy

    Kenji Chamoto;Ryusuke Hatae;Tasuku Honjo

    (2020)
    162 Citations
  • Combination therapy with PD-1 or PD-L1 inhibitors for cancer

    Hidetoshi Hayashi;Kazuhiko Nakagawa

    (2020)
    111 Citations
  • Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2020 for the Clinical Practice of Hereditary Colorectal Cancer

    Naohiro Tomita;Hideyuki Ishida;Kohji Tanakaya;Tatsuro Yamaguchi

    (2021)
    105 Citations
  • Optimizing antiemetic treatment for chemotherapy-induced nausea and vomiting in Japan: Update summary of the 2015 Japan Society of Clinical Oncology Clinical Practice Guidelines for Antiemesis.

    Kenjiro Aogi;Hideki Takeuchi;Toshiaki Saeki;Keisuke Aiba

    (2021)
    81 Citations
  • Clinical Practice Guidelines for Pancreatic Cancer 2022 from the Japan Pancreas Society: a synopsis

    (2023)
    77 Citations
  • Clinical practice guidance for next-generation sequencing in cancer diagnosis and treatment (edition 2.1).

    Yoichi Naito;Hiroyuki Aburatani;Toraji Amano

    (2021)
    71 Citations
  • Apalutamide, enzalutamide, and darolutamide for non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis.

    Keiichiro Mori;Keiichiro Mori;Hadi Mostafaei;Hadi Mostafaei;Benjamin Pradere;Benjamin Pradere;Reza Sari Motlagh

    (2020)
    62 Citations
  • Immune-resistant mechanisms in cancer immunotherapy.

    Yutaka Kawakami;Yutaka Kawakami;Shigeki Ohta;Mohammad A. Sayem;Nobuo Tsukamoto

    (2020)
    54 Citations
  • Japan Society of Clinical Oncology Clinical Practice Guidelines 2017 for fertility preservation in childhood, adolescent, and young adult cancer patients: part 1

    (2022)
    39 Citations
  • Lymphocyte-to-C-reactive protein ratio as a prognostic factor for hepatocellular carcinoma.

    Norifumi Iseda;Shinji Itoh;Tomoharu Yoshizumi;Takahiro Tomiyama

    (2021)
    39 Citations

Related Online Degrees & Career Pathways

For those interested in expanding their medical knowledge beyond traditional medicine, numerous related online degrees offer flexible learning and diverse career opportunities. Pursuing an best doctorate of healthcare administration programs can prepare professionals for leadership roles within healthcare organizations, focusing on management, policy, and operational efficiency.

Pharmacy is another critical field with growing demand. Enrolling in an online pharmacy school allows students to develop expertise in medication therapy, patient safety, and pharmaceutical sciences, opening doors to careers as pharmacists or pharmaceutical researchers.

For those fascinated by human movement and physical fitness, an online bachelor's degree in exercise science offers foundational knowledge that supports careers in personal training, rehabilitation, and wellness coaching.

Additionally, an online kinesiology degree emphasizes understanding bodily functions and biomechanics, which is essential for roles in physical therapy, sports science, and occupational therapy.

Exploring these related fields can enhance your medical career, providing specialized skills and alternative pathways within the healthcare industry.

Best Scientists Contributing to This Journal

Recently Published Articles